Liselotte Hyveled
Direktor/Vorstandsmitglied bei NOVO NORDISK A/S
Profil
Liselotte Hyveled is currently the Chief Patient Officer & Non-Independent Director at Novo Nordisk A.
She is also a Director at RSP Systems A and a Director at TriSalus Life Sciences, Inc. starting in 2024.
Previously, she worked as a Director at Novo Nordisk A from 1992 to 2018, with a specific role as Director from 2014 to 2018.
She also held a Director position at Novo Nordisk Ltd.
Ms. Hyveled completed her graduate degree at Copenhagen Business School in 2011 and another graduate degree at the University of Copenhagen in 1992.
Aktive Positionen von Liselotte Hyveled
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVO NORDISK A/S | Direktor/Vorstandsmitglied | 24.03.2022 |
| TRISALUS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | 07.05.2024 |
RSP Systems A/S
 RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Liselotte Hyveled
| Unternehmen | Position | Ende |
|---|---|---|
| NOVO NORDISK A/S | Direktor/Vorstandsmitglied | 22.03.2018 |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Liselotte Hyveled
| University of Copenhagen | Graduate Degree |
| Copenhagen Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| TRISALUS LIFE SCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
RSP Systems A/S
RSP Systems A/S Medical SpecialtiesHealth Technology RSP Systems A/S provides non-invasive solutions for sugar and insulin blood level measurements. Its products are used to make measurements of molecules in terms of identification and quantities. The company was founded by Olav Storm Kjestrup, Stefan Banke, and Morten Henneberg in May 2006 and is headquartered in Odense, Denmark | Health Technology |
Novo Nordisk Ltd.
Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Health Services |